Post Profile

U.S. FDA clears Xarelto blood thinner despite faulty trial device

(Reuters) - The U.S. Food and Drug Administration on Tuesday said it has determined the widely-used blood thinner Xarelto to be safe and effective for patients with the heart condition atrial fibrillation after serious doubts arose over the major study used to gain approval of the drug.
read more


Related Posts

FDA Approves Multaq(R) For Patients With Atrial Fibrillation Or Atrial Flutter

Health : Medical News Today

Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced that the U.S. Food and Drug Administration (FDA) has approved Multaq(R) (dronedarone) 400 mg Tablets. Patients with atrial fibrillation (AF) or atrial flutter (AFL) soon will ha...

Blood Thinners on "as Needed" Basis Is Safe and Effective for Lowering Stroke Risk as Compared to Long-Term Use

Health : Newswise Medical News

Patients with atrial fibrillation (AF), a rapid irregular heartbeat caused by pooling blood in the heart which can lead to heart failure and stroke, are often treated with an ablation, a minimally invasive procedure used to remove t...

Xarelto (Rivaroxaban) Recommended For Patients With Non-valvular Atrial Fibrillation, USA

Health : Medical News Today

Anticoagulant Xarelto (rivaroxaban) has been recommended by the FDA's Cardiovascular Renal Drugs Advisory Committee for the prevention of systemic embolism and stroke in patients with non-valvular AF (atrial fibrillation). The Commi...

Xarelto (Rivaroxaban) Approved By FDA For Non-Valvular Atrial Fibrillation Patients

Health : Medical News Today

Xarelto (rivaroxaban), an anti-clotting medication, has been approved by the FDA for patients with non-valvular atrial fibrillation to reduce stroke risk. Xarelto, a Factor Xa inhibitor, acts at a crucial point in the blood-clotting...

FDA Says No To Using J&J Blood Thinner To Treat Heart Disease

Industries / Medical : The Medicine Show

The Food and Drug Administration has rejected Johnson & Johnson’s blood thinner Xarelto as a treatment for heart disease for the second time. The drug is approved to prevent strokes in patients who have atrial fibrillation, a heart ...


Copyright © 2016 Regator, LLC